1. Home
  2. MATW vs ANL Comparison

MATW vs ANL Comparison

Compare MATW & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$26.63

Market Cap

825.3M

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$12.15

Market Cap

731.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
ANL
Founded
1850
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
825.3M
731.6M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
MATW
ANL
Price
$26.63
$12.15
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
237.4K
151.7K
Earning Date
04-30-2026
04-10-2026
Dividend Yield
3.67%
N/A
EPS Growth
59.07
N/A
EPS
0.69
N/A
Revenue
$1,795,737,000.00
N/A
Revenue This Year
N/A
$36.02
Revenue Next Year
N/A
N/A
P/E Ratio
$38.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.76
$0.88
52 Week High
$30.93
$17.25

Technical Indicators

Market Signals
Indicator
MATW
ANL
Relative Strength Index (RSI) 44.84 46.16
Support Level $26.48 $6.92
Resistance Level $27.87 $12.09
Average True Range (ATR) 0.81 1.34
MACD -0.11 -0.20
Stochastic Oscillator 40.40 25.57

Price Performance

Historical Comparison
MATW
ANL

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

Share on Social Networks: